1.
Bye AP, Kriek N, Sage T, Rawlings SJ, Prodger C, Kesavan M, Lees C, Booth S, Cowen LG, Shefferd K, Desborough MJ, Gibbins JM, Eyre TA. Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib. haematol [Internet]. 2023May1 [cited 2024Jun.24];108(5):1429-35. Available from: https://haematologica.org/article/view/haematol.2022.281402